In our study, we found that FBW7 was a novel E3 ligase for GSK-3β-induced degradation of NFAT1 in RCC cells, and FBW7 contributes to modulating the immune response in RCC to ICIs therapy partially through NFAT1. The gene discussed is FBXW7; the disease is renal cell carcinoma.